Author

Johann Zimmermann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alberto J. ArribasiD· 1 shared Anastasios StathisiD· 1 shared Andrea RinaldiiD· 1 shared Chiara TarantelliiD· 1 shared Davide RossiiD· 1 shared Eleonora CannasiD· 1 shared Elisa CivanelliiD· 1 shared Emanuele ZuccaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alberto J. ArribasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 10, 2025

Pharmacological inhibition of CXCR4 increases the anti-tumor activity of conventional and targeted therapies in B-cell lymphoma models

Laura Barnabei, Alberto J. Arribas, Luciano Cascione…·Francesco Bertoni

This study shows that combining CXCR4 inhibitors with standard and targeted therapies improves anti-tumor effects in B-cell lymphoma models, especially in drug-resistant cases.

DOI 10.1101/2025.07.10.664047

humanbulk RNA-seq

𝕏 PostBluesky